
安罗替尼治疗晚期非小细胞肺癌的成本-效果分析*
Cost-effectiveness Analysis of Anlotinib for Advanced Non-Small Cell Lung Cancer
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |